Bjerke et al. suggested TIMP-1 and MMP-9 as AD biomarkers, next to P-tau, T-tau, white matter lesions, and Aβ1–42, in order to outlook the association between AD and MMPs [126,127]. This evidence concerns the gene MMP9 and Alzheimer disease.